POMALIDOMIDE BIOEQUIVALENCE STUDY IN HEALTHY VOLUNTEERS

Clinical trials for POMALIDOMIDE BIOEQUIVALENCE STUDY IN HEALTHY VOLUNTEERS explained in plain language.

Never miss a new study

Get alerted when new POMALIDOMIDE BIOEQUIVALENCE STUDY IN HEALTHY VOLUNTEERS trials appear

Sign up with your email to follow new studies for POMALIDOMIDE BIOEQUIVALENCE STUDY IN HEALTHY VOLUNTEERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Generic cancer drug candidate put to the test

Knowledge-focused Completed

This study compares a new capsule form of pomalidomide (Xetrane) with the approved drug Imnovid in healthy male volunteers. The goal is to see if the two versions are absorbed and processed by the body in the same way. Participants receive a single dose of each capsule on separat…

Matched conditions: POMALIDOMIDE BIOEQUIVALENCE STUDY IN HEALTHY VOLUNTEERS

Phase: PHASE1 • Sponsor: Knight Therapeutics (USA) Inc • Aim: Knowledge-focused

Last updated Jul 12, 2026 00:00 UTC

POMALIDOMIDE BIOEQUIVALENCE STUDY IN HEALTHY VOLUNTEERS

Get alerted when new POMALIDOMIDE BIOEQUIVALENCE STUDY IN HEALTHY VOLUNTEERS trials appear

Generic cancer drug candidate put to the test